Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Inventory (2023 - 2025)

Historic Inventory for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $2.2 million.

  • BioLineRx's Inventory fell 3845.94% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 3845.94%. This contributed to the annual value of $3.1 million for FY2024, which is 6103.43% up from last year.
  • As of Q3 2025, BioLineRx's Inventory stood at $2.2 million, which was down 3845.94% from $2.8 million recorded in Q2 2025.
  • In the past 5 years, BioLineRx's Inventory ranged from a high of $3.6 million in Q2 2024 and a low of $1.4 million during Q3 2023
  • Its 3-year average for Inventory is $2.8 million, with a median of $2.9 million in 2024.
  • Per our database at Business Quant, BioLineRx's Inventory skyrocketed by 16213.02% in 2024 and then plummeted by 3845.94% in 2025.
  • BioLineRx's Inventory (Quarter) stood at $2.0 million in 2023, then soared by 61.03% to $3.1 million in 2024, then plummeted by 30.65% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.8 million for Q2 2025, and $3.3 million during Q1 2025.